Your browser doesn't support javascript.
loading
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype.
Yamada, Walter; Kim, Sarah; Almoslem, Mohammed; Kim, Soyoung; Myrick, Jenny; Nole, Jocelyn; Duncanson, Brandon; Louie, Arnold; Peloquin, Charles A; Schmidt, Stephan; Drusano, George L; Neely, Michael.
Afiliación
  • Yamada W; Laboratory of Applied Pharmacokinetics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Kim S; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Almoslem M; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Kim S; Department of Clinical Pharmacy, University of Ha'il, Ha'il, Kingdom of Saudi Arabia.
  • Myrick J; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Nole J; Institute for Therapeutic Innovation, College of Medicine, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Duncanson B; Institute for Therapeutic Innovation, College of Medicine, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Louie A; Institute for Therapeutic Innovation, College of Medicine, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Peloquin CA; Institute for Therapeutic Innovation, College of Medicine, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Schmidt S; Infectious Disease Pharmacokinetics Lab, College of Pharmacy and Emerging Pathogens Institute, University of Floridagrid.15276.37, Gainesville, Florida, USA.
  • Drusano GL; Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Floridagrid.15276.37, Orlando, Florida, USA.
  • Neely M; Institute for Therapeutic Innovation, College of Medicine, University of Floridagrid.15276.37, Orlando, Florida, USA.
Antimicrob Agents Chemother ; 66(10): e0069522, 2022 10 18.
Article en En | MEDLINE | ID: mdl-36165631
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Asunto principal: Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Asunto principal: Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos